Leerink Partnrs Analysts Lift Earnings Estimates for ARDT

Ardent Health Partners, LLC (NYSE:ARDT - Free Report) - Leerink Partnrs boosted their Q4 2025 earnings per share estimates for Ardent Health Partners in a report issued on Tuesday, April 1st. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $0.68 per share for the quarter, up from their prior forecast of $0.61. The consensus estimate for Ardent Health Partners' current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health Partners' Q1 2026 earnings at $0.38 EPS, Q2 2026 earnings at $0.57 EPS, Q3 2026 earnings at $0.46 EPS and Q4 2026 earnings at $0.66 EPS.

ARDT has been the topic of several other research reports. Royal Bank of Canada reduced their price objective on shares of Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating on the stock in a research note on Tuesday, March 4th. Truist Financial decreased their price objective on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Morgan Stanley dropped their target price on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a research note on Tuesday, January 21st. Stephens reissued an "overweight" rating and issued a $22.00 price target on shares of Ardent Health Partners in a research note on Tuesday, April 1st. Finally, JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $20.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Two research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $21.18.

Remove Ads

Ardent Health Partners Trading Down 0.9 %

Shares of ARDT traded down $0.11 during mid-day trading on Thursday, reaching $11.95. 78,504 shares of the company's stock were exchanged, compared to its average volume of 406,530. The company has a 50-day simple moving average of $14.19 and a two-hundred day simple moving average of $16.01. Ardent Health Partners has a 52-week low of $11.60 and a 52-week high of $20.72. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.50 by $0.31. The company had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion.

Hedge Funds Weigh In On Ardent Health Partners

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Ardent Health Partners during the fourth quarter worth approximately $27,000. US Bancorp DE bought a new position in Ardent Health Partners in the fourth quarter valued at approximately $31,000. R Squared Ltd acquired a new position in shares of Ardent Health Partners in the fourth quarter valued at approximately $37,000. BNP Paribas Financial Markets acquired a new position in Ardent Health Partners in the 3rd quarter worth $42,000. Finally, New York State Common Retirement Fund bought a new position in shares of Ardent Health Partners during the fourth quarter worth about $48,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.